Abstract
The isolation of human induced pluripotent stem cells (iPSCs)1,2,3 offers a new strategy for modelling human disease. Recent studies have reported the derivation and differentiation of disease-specific human iPSCs4,5,6,7. However, a key challenge in the field is the demonstration of disease-related phenotypes and the ability to model pathogenesis and treatment of disease in iPSCs. Familial dysautonomia (FD) is a rare but fatal peripheral neuropathy, caused by a point mutation in the IKBKAP8 gene involved in transcriptional elongation9. The disease is characterized by the depletion of autonomic and sensory neurons. The specificity to the peripheral nervous system and the mechanism of neuron loss in FD are poorly understood owing to the lack of an appropriate model system. Here we report the derivation of patient-specific FD-iPSCs and the directed differentiation into cells of all three germ layers including peripheral neurons. Gene expression analysis in purified FD-iPSC-derived lineages demonstrates tissue-specific mis-splicing of IKBKAP in vitro. Patient-specific neural crest precursors express particularly low levels of normal IKBKAP transcript, suggesting a mechanism for disease specificity. FD pathogenesis is further characterized by transcriptome analysis and cell-based assays revealing marked defects in neurogenic differentiation and migration behaviour. Furthermore, we use FD-iPSCs for validating the potency of candidate drugs in reversing aberrant splicing and ameliorating neuronal differentiation and migration. Our study illustrates the promise of iPSC technology for gaining new insights into human disease pathogenesis and treatment.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Yu, J. et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917–1920 (2007)
Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861–872 (2007)
Park, I. H. et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451, 141–146 (2008)
Dimos, J. T. et al. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 131, 1218–1221 (2008)
Ebert, A. D. et al. Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 457, 277–280 (2009)
Park, I. H. et al. Disease-specific induced pluripotent stem cells. Cell 134, 877–886 (2008)
Soldner, F. et al. Parkinson’s disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell 136, 964–977 (2009)
Slaugenhaupt, S. A. et al. Tissue-specific expression of a splicing mutation in the IKBKAP gene causes familial dysautonomia. Am. J. Hum. Genet. 68, 598–605 (2001)
Close, P. et al. Transcription impairment and cell migration defects in elongator-depleted cells: implication for familial dysautonomia. Mol. Cell 22, 521–531 (2006)
Axelrod, F. B., Goldberg, J. D., Ye, X. Y. & Maayan, C. Survival in familial dysautonomia: impact of early intervention. J. Pediatr. 141, 518–523 (2002)
Anderson, S. L. et al. Familial dysautonomia is caused by mutations of the IKAP gene. Am. J. Hum. Genet. 68, 753–758 (2001)
Slaugenhaupt, S. A. et al. Rescue of a human mRNA splicing defect by the plant cytokinin kinetin. Hum. Mol. Genet. 13, 429–436 (2004)
Papapetrou, E. P. et al. Stoichiometric and temporal requirements of Oct4, Sox2, Klf4 and cMyc expression for efficient human iPSC induction and differentiation. Proc. Natl Acad. Sci. USA 106, 12759–12764 (2009)
Elkabetz, Y. et al. Human ES cell-derived neural rosettes reveal a functionally dinstinct early neural stem cell stage. Genes Dev. 22, 152–165 (2008)
Lee, G. et al. Isolation and directed differentiation of neural crest stem cells derived from human embryonic stem cells. Nature Biotechnol. 25, 1468–1475 (2007)
Lee, G. S., Kim, B. S., Sheih, J. H. & Moore, M. Forced expression of HoxB4 enhances hematopoietic differentiation by human embryonic stem cells. Mol. Cells 25, 487–493 (2008)
Lu, S. J. et al. Generation of functional hemangioblasts from human embryonic stem cells. Nature Methods 4, 501–509 (2007)
D’Amour, K. A. et al. Efficient differentiation of human embryonic stem cells to definitive endoderm. Nature Biotechnol. 23, 1534–1541 (2005)
Iwashita, T., Kruger, G. M., Pardal, R., Kiel, M. J. & Morrison, S. J. Hirschsprung disease is linked to defects in neural crest stem cell function. Science 301, 972–976 (2003)
Jones, N. C. et al. Prevention of the neurocristopathy Treacher Collins syndrome through inhibition of p53 function. Nature Med. 14, 125–133 (2008)
Sommer, L., Shah, N., Rao, M. & Anderson, D. J. The cellular function of MASH1 in autonomic neurogenesis. Neuron 15, 1245–1258 (1995)
Johansen, L. D. et al. IKAP localizes to membrane ruffles with filamin A and regulates actin cytoskeleton organization and cell migration. J. Cell Sci. 121, 854–864 (2008)
Anderson, S. L., Qiu, J. & Rubin, B. Y. EGCG corrects aberrant splicing of IKAP mRNA in cells from patients with familial dysautonomia. Biochem. Biophys. Res. Commun. 310, 627–633 (2003)
Anderson, S. L., Qiu, J. & Rubin, B. Y. Tocotrienols induce IKBKAP expression: a possible therapy for familial dysautonomia. Biochem. Biophys. Res. Commun. 306, 303–309 (2003)
Axelrod, F. B. Familial dysautonomia: a review of the current pharmacological treatments. Expert Opin. Pharmacother. 6, 561–567 (2005)
Perrier, A. L. et al. From the Cover: derivation of midbrain dopamine neurons from human embryonic stem cells. Proc. Natl Acad. Sci. USA 101, 12543–12548 (2004)
Placantonakis, D. G. et al. BAC transgenesis in human ES cells as a novel tool to define the human neural lineage. Stem Cells 27, 521–532 (2009)
Chambers, S. M. et al. Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nature Biotechnol. 27, 275–280 (2009)
Kennedy, M., D’Souza, S. L., Lynch-Kattman, M., Schwantz, S. & Keller, G. Development of the hemangioblast defines the onset of hematopoiesis in human ES cell differentiation cultures. Blood 109, 2679–2687 (2007)
Rodriguez, L. G., Wu, X. & Guan, J. L. Wound-healing assay. Methods Mol. Biol. 294, 23–29 (2005)
Acknowledgements
We thank J. Hendrikx, M. Leversha and C. Zhao for technical help. The work was supported by grants from the Starr Foundation and NYSTEM, by the New York Stem Cell Foundation (NYCSF, Druckenmiller fellowships to G.L. and C.A.F.) and by the Starr Scholar fellowship to S.M.C.
Author Contributions G.L.: conception and study design, maintenance and directed differentiation of iPSCs, cellular/molecular assays for disease modelling, data assembly, analysis and interpretation, and writing of manuscript; E.P.P., H.K. and C.A.F.: iPSC clone derivation and maintenance; S.M.C., M.J.T. and A.V.: data collection, analysis and interpretation; Y.M.G., J.M. and F.S.: in vivo experiments and histological analyses; V.T. and M.S.: study design, data analysis and interpretation; L.S.: conception and study design, data analysis and interpretation, and writing of manuscript.
Author information
Authors and Affiliations
Corresponding author
Supplementary information
Supplementary Information
This file contains Supplementary Figures 1-11 with Legends and Supplementary Tables 1-3. (PDF 3340 kb)
Supplementary Movie 1
This movie, shows in real-time beating putative cardiomyocytes derived from FD human iPS cell line (clone#22). (MOV 1730 kb)
Rights and permissions
About this article
Cite this article
Lee, G., Papapetrou, E., Kim, H. et al. Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs. Nature 461, 402–406 (2009). https://doi.org/10.1038/nature08320
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nature08320
This article is cited by
-
Transcriptome analysis in a humanized mouse model of familial dysautonomia reveals tissue-specific gene expression disruption in the peripheral nervous system
Scientific Reports (2024)
-
Investigation of immune-related diseases using patient-derived induced pluripotent stem cells
Inflammation and Regeneration (2023)
-
Focus on your locus with a massively parallel reporter assay
Journal of Neurodevelopmental Disorders (2022)
-
Norepinephrine transporter defects lead to sympathetic hyperactivity in Familial Dysautonomia models
Nature Communications (2022)
-
Passage number affects differentiation of sensory neurons from human induced pluripotent stem cells
Scientific Reports (2022)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.